Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03202940 |
|---|---|
| Brief Title: | A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC |
| First Submitted : | June 12, 2017 |
| First Submitted that Met QC Criteria : | June 26, 2017 |
| First Posted : | June 29, 2017 |
| Last Update Submitted that Met QC Criteria : | April 22, 2024 |
| Last Update Posted : | April 23, 2024 |